Biology of SV40-Specific Transplantation Antigen
Biology of SV40-Specific Transplantation Antigen
批准号:
7237983
负责人:
Todd D Schell
金额:
$63.11万
依托单位国家:
美国
项目类别:
财政年份:
1978
资助国家:
美国
项目状态:
已结题
起止时间:
1978-06-01 至 2009-05-31
关键词:
Biological FactorsBiologyC57BL/6 MouseCD8B1 geneCellsChoroid Plexus NeoplasmsCytotoxic T-LymphocytesDNADNA VirusesDevelopmentEpitopesGrantHistocompatibility AntigensImmuneImmune responseImmunizationImmunodominant EpitopesImmunologic SurveillanceIn VitroLightLymphocyteMaintenanceMalignant NeoplasmsMature T-LymphocyteMediatingModelingMusMutationNatureNeoplasm MetastasisNeoplasmsNormal CellOncogenesOncogenic VirusesPancreasPeripheralPhenotypePlayPositioning AttributeRoleSV40 T AntigensSimian virus 40SiteSystemT memory cellT-Cell ReceptorT-LymphocyteTissuesTransgenesTransgenic MiceTransgenic OrganismsVaccinia virusVariantViral Tumor Antigensbasecell mediated immune responsecell transformationdesignin vivoinsightosteosarcomapromoterreconstitutionresponsesialosyl-T antigentumortumor growthtumor progressiontumorigenicvaccinia virus vector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SV40 is a small DNA containing tumor virus that encodes a 94 kD oncogene, tumor or T antigen, which converts normal cells to tumorigenic phenotype both in vitro and in vivo. T antigen-induced tumor progression is heavily influenced by the T cell-mediated immune response to T antigen. The T antigen induces CD8 ? T lymphocyte responses to four H2 b epitopes in B6 mice in a hierarchical manner (IV>I>II/III>V). In fact, CD8+ T cells specific for epitope V are not detected unless the immunodominant epitopes I, II/III and IV have been inactivated. Thus, the T antigen system provides an opportunity to study the role of CD8+ T cells specific for multiple epitopes in the control of spontaneous T antigen-induced tumors and to identify biological factors which contribute to immunodominance. In the previous grant period we characterized the T antigen-specific CD8+ T cell response in several T antigen transgenic mouse lines. Using a model of central T cell tolerance we found that adoptively transferred donor cells could be ensitized against the endogenous T antigehl leading to the induction of epitope IV-specific CD8 ? T cells that migrated to the tumor site and were associated with control of tumor progression. Additionally, we established a model of peripheral T cell tolerance in which T antigen epitope-specific CD8+ T cells were differentially tolerized before or in association with spontaneous tumor progression. Thus, the overall objectives of this project are to identify those aspects of the CD8 ? T cell immune response to T antigen which are critical for the control of spontaneous tumor progression in T antigen transgenic mice and to understand the basis for the immunorecessive nature of epitope V in the immune response to T antigen. The following four specific aims are _Dro0osed: 1. Requirements for effective CD8 ? T cell-mediated control of advanced choroid plexus tumors in T antigen transgenic mice with central CD8 ? T cell tolerance. 2. Counteracting peripheral tolerance for the control of tumor progression in T antigen transgenic mice. 3. CD8 ? T cell control of tumor metastasis in T antigen transgenic mice. 4. Immunodomination of epitope V CD8 ? T cell responses by dominant T antigen epitopes. We will utilize various models of T antigen transgenic mice and T antigen epitope-specific T cell receptor transgenic mice to determine the effect of various immunization approaches on the control of spontaneous tumor progression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuroendocrine Modulation of T Cell Immunity to Cancer
-
批准号:7842607
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2009
-
负责人:Todd D Schell
-
依托单位:
Neuroendocrine Modulation of T Cell Immunity to Cancer
-
批准号:7386476
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2009
-
负责人:Todd D Schell
-
依托单位:
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
-
批准号:7782476
-
项目类别:
-
资助金额:$38.61万
-
财政年份:1978
-
负责人:Todd D Schell
-
依托单位:
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
-
批准号:7996015
-
项目类别:
-
资助金额:$37.44万
-
财政年份:1978
-
负责人:Todd D Schell
-
依托单位:
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
-
批准号:8585821
-
项目类别:
-
资助金额:$36.31万
-
财政年份:1978
-
负责人:Todd D Schell
-
依托单位:
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
-
批准号:8196851
-
项目类别:
-
资助金额:$37.44万
-
财政年份:1978
-
负责人:Todd D Schell
-
依托单位:
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
-
批准号:8387758
-
项目类别:
-
资助金额:$35.19万
-
财政年份:1978
-
负责人:Todd D Schell
-
依托单位:
国内基金
海外基金
Journal of Integrative Plant Biology
-
批准号:31024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:贺萍
-
依托单位: